Ovarian melanoma complicating pregnancy achieved by in-vitro fertilisation

Journal of Obstetrics and Gynaecology

Volumn 33, Issue 1, 2013, Pages 89-91

  Sioulas, V D ^a   Panayiotides, I G ^a   Chrelias, C ^a   Grammatikakis, I ^a   Vaggopoulos, V ^a   Kefala, M ^a   Kassanos, D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; DEXAMETHASONE; GLYCOPROTEIN; GLYCOPROTEIN 100; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN S 100; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; BRAIN DAMAGE; BRAIN RADIATION; CANCER RADIOTHERAPY; CASE REPORT; CEREBELLUM; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CYTOLOGY; DISEASE DURATION; DIZZINESS; FEMALE; FERTILIZATION IN VITRO; FRONTAL LOBE; FROZEN SECTION; GESTATIONAL AGE; HEADACHE; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPROLACTINEMIA; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MEDICAL HISTORY; MELANOMA; MENINGIOMA; MORPHOLOGICAL TRAIT; MULTIPLE PULMONARY NODULES; NAUSEA; NEUROIMAGING; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTUM; OVARIECTOMY; OVARY CANCER; OVARY HYPERSTIMULATION; OVARY MELANOMA; PATIENT REFERRAL; PERITONEAL CAVITY; PHOTOPHOBIA; PREGNANCY; PREGNANCY TERMINATION; PRIMIGRAVIDA; PRIORITY JOURNAL; TUMOR CELL; TUMOR VOLUME; VOMITING;

EID: 84871515296     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2012.727502     Document Type: Note

References (10)

1. Althuis MD, Scoccia B, Lamb EJ et al. 2005. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. American Journal of Obstetrics and Gynecology 193:668-674.
2. Brinton LA, Moghissi KS, Scoccia B et al. 2005. Ovulation induction and cancer risk. Fertility and Sterility 83:261-274.
3. Fuller PN. 1999. Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature. American Journal of Obstetrics and Gynecology 180:1499-1503.
4. Hannibal CG, Jensen A, Sharif H et al. 2008. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study. Cancer Causes and Control 19:759-765.
5. Jhaveri MB, Driscoll MS, Grant-Kels JM. 2011. Melanoma in pregnancy. Clinical Obstetrics and Gynecology 54:537-545.
6. Kvaskoff M, Bijon A, Mesrine S et al. 2011. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. American Journal of Epidemiology 173:1192-1202.
7. MacKie RM, Hauschild A, Eggermont AM. 2009. Epidemiology of invasive cutaneous melanoma.Annals of Oncology 20(Suppl 6):1-7.
8. McCluggage WG, Bissonnette JP, Young RH.2006. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms. International Journal of Gynecological Pathology 25: 321-329.
9. Pentheroudakis G, Orecchia R, Hoekstra HJ et al. 2010. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 21(Suppl 5):266-273.
10. Yli-Kuha AN, Gissler M, Klemetti R et al. 2012. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Human Reproduction 27:1149-1155.